OWENS DAVID (Chief Medical Officer) purchased 2.1% of their position (3K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $1.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/12/2024ACC: 0001829126-24-004108
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+3K
Net shares
Net buyer
$1.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3K acquired
Non-Derivative Transactions2
Common stock
Direct
Shares
+2K
Price / share
$0.65
Trade value
$1.30K
% of position
1.4%
6/10/2024
141.17K→143.17K
Common stock
Direct
Shares
+1K
Price / share
$0.62
Trade value
$620.00
% of position
0.7%
6/10/2024
143.17K→144.17K
Total
Net shares
+3K
Net value
$1.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/10/2024 | P · Purchase | +2K | $0.65 | $1.30K | 1.4% | 141.17K | 143.17K |
| Common stock Direct | 6/10/2024 | P · Purchase | +1K | $0.62 | $620.00 | 0.7% | 143.17K | 144.17K |
| Total | +3K | $1.92K | ||||||
Derivative Transactions0
No derivative transactions reported